Amodiaquine-induced dystonic reactions: Case reports and implications for policy change in Ghana

International Journal of Risk and Safety in Medicine

Volumn 17, Issue 1-2, 2005, Pages 1-4

  Akpalu Jr , A K ^a   Nyame, P K ^a   Dodoo, A N O ^a  

^a UNIVERSITY OF GHANA   (Ghana)

Author keywords

Amodiaquine; Drug induced dystonic reactions

Indexed keywords

AMODIAQUINE; BENZATROPINE; DIAZEPAM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; DYSTONIA; EMERGENCY WARD; FEMALE; GHANA; HEALTH CARE POLICY; HUMAN; MALARIA; MALE; NEUROTOXICITY;

EID: 23944492351     PISSN: 09246479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. M.O. Akindele and A.O. Odejide, Amodiaquine induced involuntary movements, Brit. Med. J. 2(6029) (1976), 214-215.
2. Antimalarial drugs: Amodiaquine in: Martindale, The Complete Drug Reference. 23rd, S.C. Sweetman, ed., Pharmaceutical Press, Bath, 2003, pp. 430-433.
3. H. Bareness, N. Nagot, I. Valea, T. Koussoube-Balima, A. Ouedrago, T. Sanou and S. Ye, A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso, Trop. Med. Int. Health 9 (2004), 438-444.
4. G. Christie, A.M. Breckenridge and B.K. Park, Drug-protein conjugates - XVIII. Detection of antibodies towards the antimalarial amodiaquine and its quinone imine metabolite in man and the rat, Biochem. Pharmacol. 38 (1989), 1451-1458.
5. G.A. Luzzi and T.E. Peto, Adverse effects of antimalarials. An update, Drug Saf. 8 (1993), 295-311.
6. National Malaria Policy, 2004. Ghana National Malaria Control Programme, Ghana Health Service, 2004.
7. M. Ndounga and L.K. Basco, Rapid clearance of Plasmodium falciparum hyperparasitaemia after oral amodiaquine treatment in patients with uncomplicated malaria, Acta Trop. 88 (2003), 27-32.
8. K.A. Neftel, W. Woodtly, M. Schmid, P.G. Frick and J. Fehr, Amodiaquine induced agranulocytosis and liver damage, Br. Med. J. (Clin. Res. Ed.) 292(6522) (1986), 721-723.
9. P. Olliaro and P. Mussano (Review Group: Cochrane Infectious Diseases Group), Amodiaquine for treating malaria. The Cochrane Database of Systematic Reviews; Substantively amended: 26 February 2003; unmodified this issue. (AN: CD000016.)
10. N.G. Osifo, Drug related transient dyskinesias, Clin. Pharmacol. Exp. Ther. 25 (1979), 767-771.
11. P.A. Phillips-Howard and A.B. Bjorkman, Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs, Bull. World Health Organ. 68 (1990), 493-504.
12. P.A. Phillips-Howard and L.J. West, Serious adverse drug reactions to pyrimethamine-sulphadoxine-pyrimethamine-dapsone and to amodiaquine in Britain, J. R. Soc. Med. 83 (1990), 82-85.
13. W.R. Taylor and N.J. White. Antimalarial drug toxicity: a review. Drug Saf. 27 (2004), 25-61.
14. F. Thomas, A. Erhart and U. D'Alessandro, Can amodiaquine be used safely during pregnancy?, Lancet Infect. Dis. 4 (2004), 235-239.
15. P.A. Winstanley, O. Simooya, J.M. Kofi-Ekue, O. Walker, L.A. Salako, G. Edwards, M.L. Orme and A.M. Breckenridge, The disposition of amodiaquine in Zambians and Nigerians with malaria, Br. J. Clin. Pharmacol. 29 (1990), 695-701.